Nakamoto Inc.

NASDAQ:NAKA

Financial - Capital Markets

Financial Services
$4.45 +0.03%

+$0.00 today

Market cap
$77.44M
Beta
-0.90
P/E (TTM)
-0.2
EPS (TTM)
-$18.22
52W Low $4.05High $679.20

Volume 0.13M

Average 0.24M

NAKA Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Nakamoto Inc.NASDAQ: NAKA

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q1 FY2026 accounts payables was -$6.23M, compared with $48K a year earlier. Trailing-twelve-month accounts payables was -$8.24M.

Context

  • Accounts payables amounted to 107.3% of revenue in FY2025, up 107.1 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -$6.23M or moves back toward the trailing-twelve-month quarterly average of -$2.06M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$6.23M+1644.3% QoQ
Last fiscal yearDec 2025
-$1.95M+32010.7% YoY
LTMMar 2026
-$8.24M-11230.1% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-13087.5%——
1 year+32010.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(1.95M) USD
Year-over-year change
-32010.7%

Accounts Payables vs competitors

How NAKA compares with its peers on the latest reported figures

  • NAKA's LTM Mar 2026 accounts payables of $8.24M is the 3rd largest of the 11 companies compared; the peer median is $3.02M.
  • Its year-over-year change of -11230.1% is the lowest of 10, against a peer median of +135.6%.
  • Accounts payables amounts to 210.1% of revenue for NAKA, versus a peer median of 4.0%.
NAKA Competitors Peer median
Accounts Payables for NAKA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AMRNAmarin Corporation plcLTM Mar 2026$17.22M +128.8%—8.0%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$12.45M +595.4%—15.3%
NAKANakamoto Inc.LTM Mar 2026$8.24M -11230.1%—210.1%
LRMRLarimar Therapeutics, Inc.LTM Mar 2026$5.87M +736.9%+375.3%—
DCTHDelcath Systems, Inc.LTM Mar 2026$5.42M +544.5%+38.4%6.0%
DBVTDBV Technologies S.A.LTM Mar 2026$4.34M -72.9%+66.1%—
DHDefinitive Healthcare Corp.LTM Mar 2026$3.92M -34.4%—1.6%
LYELLyell Immunopharma, Inc.LTM Mar 2026$1.7M +135.6%—5477.4%
CLLSCellectis S.A.LTM Mar 2026$1.34M -181.1%—2.0%
SLPSimulations Plus, Inc.LTM Feb 2026$403K +352.8%-6.6%0.5%
AGLAgilon Health, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding NAKA) $3.02M+135.6%+52.2%4.0%

Competitors are the stored peer set for NAKA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income149.34K(2.54M)(1.62M)(3.62M)(52.23M)
Depreciation & Amortization63.4K122.01K203.22K220.33K241.99K
Deferred Income Tax00000
Stock-Based Compensation02.22M414.69K240.92K2.36M
Change in Working Capital(91.29K)33.23K116.36K(301.97K)(4.05M)
Accounts Receivables401(7.12K)(15.88K)(40.96K)0
Inventory(30.64K)10.2K(13.63K)58.9K0
Accounts Payables0122.31K163.55K(6.09K)(1.95M)
Other Working Capital(61.05K)(92.16K)(17.68K)(313.82K)(2.1M)
Other Non-Cash Items128.63K433.7K384.48K30.17M
Operating Cash Flow121.44K(140.38K)(449.49K)(3.07M)(23.51M)
Capital Expenditures(63.6K)(317.39K)(14.42K)(401.63K)(234.38K)
Acquisitions (Net)0000(29.82M)
Purchases of Investments00000
Sales of Investments00005.05M
Other Investing Activities000(388.34K)(655.02M)
Investing Cash Flow(63.6K)(317.39K)(14.42K)(401.63K)(680.02M)
Debt Repayment(47.34K)150K802.49K(614.86K)191.21M
Common Stock Issued2K400K05.86M523.74M
Common Stock Repurchased000(22.15K)(320.4K)
Dividends Paid00000
Other Financing Activities00009.22M
Financing Cash Flow(45.34K)550K802.49K5.22M723.85M
Effect of Forex Changes82.19K0000
Net Change in Cash94.69K92.23K338.58K1.75M20.31M
Free Cash Flow57.84K(457.77K)(463.91K)(3.48M)(23.75M)

Nakamoto Inc.

NASDAQ:NAKA

Intrinsic Alpha fair value

Locked

Current Price

$4.45

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.